November is Hyperhidrosis Awareness Month, and dermatology clinicians are gearing up for another month of raising awareness to improve patient outcomes.
The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.
The most critical step is understanding what value precision medicine brings to your practice, and where it can have greatest impact from both a clinical and business perspective.
Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.
This CME credit opportunity delves into the pathogenesis and management of hidradenitis suppurativa.
Allergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.
In case you missed it, this week we had news about the AHEAD atopic dermatitis treatment recommendations, positive long-term results for roflumilast cream 0.05% in pediatric patients, line-field optical coherence tomography for dermal fillers, and more.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
In this expert Q&A, dermatologist Jeffrey Cizenski, MD, FAAD, offers perspectives on National Eczema Awareness Month and AbbVie's Under My Skin documentary.
Bissonnette shared highlights and insights on the icotrokinra data presented at the AAD Annual Meeting.
By staying authentic and leveraging real patient experiences, Tomassian ensures his content remains valuable and trustworthy.
The fully human monoclonal antibody is currently approved in more than 60 countries.
Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.
What's new in the treatment of mucoid pseudocysts? An international researcher and clinicians shares insights.
Jeremy Youse, M.D., founding partner, medical director and practicing dermatologist at VitalSkin Dermatology discusses which tasks he and other dermatologists want control over to get the most out of practicing and running their offices efficiently each day.
Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.
A survey asked dermatologists whether they had personal treated head and neck melanoma with excision, and if and when they referred patients with melanoma on the head and neck to a Mohs surgeon.
With the release of three brand-new products, ALASTIN Skincare® is introducing a new line of sensitive skin products that include our proprietary TriHex Technology® along with other active ingredients.
With the right strategies and a clear vision, retirement can unfold as a rewarding chapter.
A prebiotic cleanser and moisturizer regimen not only significantly alleviated the severity of atopic dermatitis and xerosis, but also uncovered crucial differences in symptom experiences.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.
Lenvatinib and pembrolizumab continued to yield meaningful and durable responses in patients with advanced melanoma who had progressed on previous PD-L1 inhibitor treatment.
In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.